Group Energy Balance and Obesity, Institut National de la Santé et de la Recherche Médicale, Unité 862, Neurocentre Magendie, 146 Rue Léo Saignat, F-33077 Bordeaux, France.
Endocrinology. 2012 Sep;153(9):4136-43. doi: 10.1210/en.2012-1405. Epub 2012 Jul 9.
Cannabinoid type 1 (CB(1)) receptor activation is generally considered a powerful orexigenic signal and inhibition of the endocannabinoid system is beneficial for the treatment of obesity and related metabolic diseases. The hypothalamus plays a critical role in regulating energy balance by modulating both food intake and energy expenditure. Although CB(1) receptor signaling has been implicated in the modulation of both these mechanisms, a complete understanding of its role in the hypothalamus is still lacking. Here we combined a genetic approach with the use of adeno-associated viral vectors to delete the CB(1) receptor gene in the adult mouse hypothalamus and assessed the impact of such manipulation on the regulation of energy balance. Viral-mediated deletion of the CB(1) receptor gene in the hypothalamus led to the generation of Hyp-CB(1)-KO mice, which displayed an approximately 60% decrease in hypothalamic CB(1) receptor mRNA levels. Hyp-CB(1)-KO mice maintained on a normocaloric, standard diet showed decreased body weight gain over time, which was associated with increased energy expenditure and elevated β(3)-adrenergic receptor and uncoupling protein-1 mRNA levels in the brown adipose tissue but, surprisingly, not to changes in food intake. Additionally, Hyp-CB(1)-KO mice were insensitive to the anorectic action of the hormone leptin (5 mg/kg) and displayed a time-dependent hypophagic response to the CB(1) inverse agonist rimonabant (3 mg/kg). Altogether these findings suggest that hypothalamic CB(1) receptor signaling is a key determinant of energy expenditure under basal conditions and reveal its specific role in conveying the effects of leptin and pharmacological CB1 receptor antagonism on food intake.
大麻素 1 型(CB1)受体的激活通常被认为是一种强大的食欲刺激信号,而内源性大麻素系统的抑制有利于肥胖和相关代谢性疾病的治疗。下丘脑在调节能量平衡方面起着关键作用,它可以调节食物摄入和能量消耗。尽管 CB1 受体信号已被证明参与了这两种机制的调节,但对其在下丘脑中的作用仍缺乏全面的了解。在这里,我们结合了基因敲除技术和腺相关病毒载体的应用,在成年小鼠的下丘脑内敲除了 CB1 受体基因,并评估了这种操作对能量平衡调节的影响。通过病毒介导的下丘脑 CB1 受体基因敲除,产生了 Hyp-CB1-KO 小鼠,其下丘脑 CB1 受体 mRNA 水平下降了约 60%。Hyp-CB1-KO 小鼠在正常热量、标准饮食条件下维持时,随着时间的推移体重增加减少,这与能量消耗增加以及棕色脂肪组织中 β3-肾上腺素能受体和解偶联蛋白 1 mRNA 水平升高有关,但令人惊讶的是,这与食物摄入量的变化无关。此外,Hyp-CB1-KO 小鼠对激素瘦素(5mg/kg)的厌食作用不敏感,并对 CB1 反向激动剂利莫那班(3mg/kg)表现出时间依赖性的摄食反应。总之,这些发现表明,下丘脑 CB1 受体信号是基础条件下能量消耗的关键决定因素,并揭示了其在传递瘦素和药理学 CB1 受体拮抗作用对食物摄入的影响方面的特定作用。